All Infection Prevention & Control articles – Page 56
-
NewsMolecular insights may inform new treatments for drug-resistant TB
Researchers have used state-of-the-art imaging to examine two new compounds that target ATP synthase, potentially stopping TB bacteria from producing the energy they need to survive.
-
NewsD-amino acids play role in cholera bacterium’s bid to escape
Cholera bacteria use specific D-amino acids to escape unfavourable niches and form complex ecological systems, a new study shows.
-
NewsWarning as third of toddlers found to have unmet vaccination needs
A third of under-fives attending a Paediatric Emergency Department (PED) and who are eligible for pre-school boosters have unmet vaccination need according to new research.
-
NewsDUV LEDs offer rapid inactivation of human respiratory RNA viruses
A deep ultraviolet LED based on AlGaN, whose wavelength is tunable from 365 to 210 nm, is a perfect alternative to mercury lamps to inactivate human respiratory RNA viruses due to its pollution-free, small-size and energy-conservation qualities.
-
NewsStudy reveals your false teeth could give you pneumonia
Dental swabs reveal a much higher number of potentially pneumonia-causing bacteria on dentures in people with pneumonia, compared to people without, according to new research.
-
NewsResearchers develop adhesive bandage that can detect COVID-19 antibodies
Researchers at NYU Abu Dhabi have developed a new rapid testing method for COVID-19 – an adhesive bandage that relies on gold nanoparticles to quickly detect the immune antibodies in the bloodstream. These antibodies, named IgM and IgG, are naturally produced as a result of SARS-CoV-2 infection, ...
-
NewsBetter tests needed to identify Candida auris susceptibility
Commercially available antifungal susceptibility tests perform poorly for many Candida auris treatments, researchers have found.
-
NewsScientists discover small RNA that regulates bacterial infection
Researchers have identified the major mechanism behind the transition between chronic and acute P. aeruginosa infections.
-
NewsEngland on track to end new HIV transmissions by 2030
New HIV transmissions in England have fallen by almost a third since 2019, according to an update on the HIV Action Plan for England.
-
NewsBiological clocks of people and malaria parasites tick in tune
Research could pave the way to new anti-malarials that work by ’jet-lagging’ the parasites that cause the disease.
-
NewsAI deployed to find promising antibiotic to fight evasive hospital superbug
Scientists have used artificial intelligence to discover a new antibiotic which could be used to fight a deadly, drug-resistant pathogen that strikes vulnerable hospital patients.
-
NewsTrial aims to improve treatment for newborns with sepsis
An international clinical trial will evaluate much-needed new antibiotic combinations for newborn babies with life-threatening sepsis.
-
OpinionThe threat of viral zoonosis hasn’t gone away
Why we’re liable to be ambushed by viral zoonosis - despite everything we’ve learned from Covid
-
NewsMonkeypox virus remains stable on surfaces for days
Researchers warn that it is extremely important to disinfect surfaces to decrease the risk of monkeypox in the event of an outbreak.
-
NewsSecond gene implicated in malaria chloroquine resistance evolution
How malaria parasites evolved to evade a major antimalarial drug has long been thought to involve only one key gene. Now, scientists have shown a second key gene is also involved in malaria’s resistance to the drug chloroquine.
-
NewsMeet Ginger: the gene-edited calf resistant to BVDV
Scientists introduce Ginger, the first gene-edited calf with reduced susceptibility to a major viral pathogen.
-
NewsFaecal beads target serious intestinal infections
Researchers have developed small beads to be taken orally, which could radically improve the administration of faecal microbiota transplantation to treat Clostridioides difficile infection.
-
NewsMeasles surge sparks UK government vaccine call
The UK government has urged parents to make sure their children’s MMR vaccine is up to date following a rise of measles cases.
-
NewsMonoclonal antibody programme targets mucormycosis
Vitalex Biosciences has been awarded an SBIR Phase 2 grant from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health for VX-01, a monoclonal antibody (mAB) programme targeting the debilitating indication of the fungal disease, mucormycosis.
-
NewsAntimicrobial foam targets bugs or oil spills
A versatile new foam material could significantly reduce health care-related infections caused by implanted medical devices - or drastically improve cleanup efforts following environmental disasters like oil spills.